EMERGING BIOTECH

Achieve Launch Excellence
with Confidence and Speed

Getting your innovation to
patients, faster.
Get Your Launch Readiness Review
The Rise of
First-Time Launchers
50%
of all product launches will be by pre-commercial companies by 2025
The Execution
Challenge
39%
of first-time launchers achieve
their sales forecast
Pre-Commercial Success
Starts with Digital
70%
of biotechs launch their first
brands with Veeva
The European
Opportunity
35%
of revenue from international drug launches come from outside the U.S.

Four Steps to Achieve Biopharma Launch Excellence

Learn how biotechs accelerate their first drug launches with data, software, and consulting.

Download eBook Watch a Demo
“We chose to use both Vault MedComms and Vault PromoMats during launch to get medical and promotional content out in a compliant way and ensure to our stakeholders that crossover will never happen.”

Bas Van de Kamp, Director Medical Affairs Systems, Idorsia

Learn How to Succeed in Your Launch Strategy, From Planning to Efficient Commercial Execution

Astellas: Ensuring Launch Success Read the Story
Turning Point Therapeutics: Preparing for Launch With Commercial Content Watch the Video
COUR Pharmaceuticals: Responding to the Unique Challenges of Rare Diseases Watch the Video

Launch Excellence Solutions for Emerging Biotech

Veeva's phased approach drives successful launches.

Veeva Business Consulting

Combine business strategy, data, and technology to drive your launch to success.

Veeva Link

Accelerate insights, precision engagement, and scientific awareness.

CRM Suite

Set the foundations for digital-first customer engagement journeys for your commercial and medical field teams.

Vault PromoMats

Launch, optimize, and scale content with speed.

Veeva OpenData

Power commercial operations with integrated customer reference data.

If you would like more information, please contact us.

Contact Us